N-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid

C26H38N14O17P3+ — CID 153452551

IUPACN-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid
SMILESCn1c[n+]([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)Cc3cn(CCNP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(=O)[nH]c(N)nc65)[C@@H](O)C4O)nn3)[C@H](O)C2O)c2nc(N)[nH]c(=O)c21
InChIInChI=1S/C26H37N14O17P3/c1-37-9-40(20-14(37)22(46)34-26(28)32-20)24-18(44)16(42)12(56-24)6-54-60(51,52)57-58(47,48)7-10-4-38(36-35-10)3-2-30-59(49,50)53-5-11-15(41)17(43)23(55-11)39-8-29-13-19(39)31-25(27)33-21(13)45/h4,8-9,11-12,15-18,23-24,41-44H,2-3,5-7H2,1H3,(H9-,27,28,30,31,32,33,34,45,46,47,48,49,50,51,52)/p+1/t11-,12-,15?,16+,17+,18?,23-,24-/m1/s1
InChIKeyNEDWUUPFGVEMEA-QGIRISAJSA-O
MW911.59 g/mol
LogP-5.10
Rot. Bonds16

About N-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid

N-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid (PubChem CID 153452551) has the molecular formula C26H38N14O17P3+ and a molecular weight of 911.59 g/mol. Its IUPAC name is N-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid.

Molecular Properties

Compound NameN-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid
PubChem CID153452551
Molecular FormulaC26H38N14O17P3+
Molecular Weight911.59 g/mol
Exact Mass911.17
IUPAC NameN-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid
SMILESCn1c[n+]([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)Cc3cn(CCNP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(=O)[nH]c(N)nc65)[C@@H](O)C4O)nn3)[C@H](O)C2O)c2nc(N)[nH]c(=O)c21
InChIInChI=1S/C26H37N14O17P3/c1-37-9-40(20-14(37)22(46)34-26(28)32-20)24-18(44)16(42)12(56-24)6-54-60(51,52)57-58(47,48)7-10-4-38(36-35-10)3-2-30-59(49,50)53-5-11-15(41)17(43)23(55-11)39-8-29-13-19(39)31-25(27)33-21(13)45/h4,8-9,11-12,15-18,23-24,41-44H,2-3,5-7H2,1H3,(H9-,27,28,30,31,32,33,34,45,46,47,48,49,50,51,52)/p+1/t11-,12-,15?,16+,17+,18?,23-,24-/m1/s1
InChIKeyNEDWUUPFGVEMEA-QGIRISAJSA-O
XLogP-5.10
TPSA451.88 Ų
H-Bond Donors12
H-Bond Acceptors24
Rotatable Bonds16
Heavy Atoms60
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500911.59
LogP ≤ 5-5.10
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze N-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid?
The IUPAC name of N-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid (CID 153452551) is N-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid.
What is the SMILES notation for N-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid?
The canonical SMILES for N-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid is Cn1c[n+]([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)Cc3cn(CCNP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(=O)[nH]c(N)nc65)[C@@H](O)C4O)nn3)[C@H](O)C2O)c2nc(N)[nH]c(=O)c21.
What is the InChIKey of N-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid?
The InChIKey is NEDWUUPFGVEMEA-QGIRISAJSA-O. The full InChI is InChI=1S/C26H37N14O17P3/c1-37-9-40(20-14(37)22(46)34-26(28)32-20)24-18(44)16(42)12(56-24)6-54-60(51,52)57-58(47,48)7-10-4-38(36-35-10)3-2-30-59(49,50)53-5-11-15(41)17(43)23(55-11)39-8-29-13-19(39)31-25(27)33-21(13)45/h4,8-9,11-12,15-18,23-24,41-44H,2-3,5-7H2,1H3,(H9-,27,28,30,31,32,33,34,45,46,47,48,49,50,51,52)/p+1/t11-,12-,15?,16+,17+,18?,23-,24-/m1/s1.
What are the key properties of N-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid?
N-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid has a molecular weight of 911.59 g/mol, XLogP of -5.10, 16 rotatable bonds, 12 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-[[[[(2R,3R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]triazol-1-yl]ethyl]-[[(2R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid is sourced from PubChem (CID 153452551), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).